New Jersey customers are saving money and energy through the PSE&G energy efficiency programs. Our latest Clean Energy Future-Energy Efficiency (CEF-EE) report highlights how our programs continue to deliver meaningful savings for customers while reducing overall energy usage and supporting the state's goals. Through March 2025, nearly 465,000 customers have actively participated in PSE&G's energy […]

Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today that it will release its financial results for the second quarter of 2025 before the market opens on Thursday, August 14, 2025. Eltek's financial results will be released over the news wires and

This Saturday, August 9, at 2pm ET, a 55-acre Tennessee property once asking $5.2 million will be sold to the highest bidder at a luxury auction® without reserve. The property sits in the foothills of the Great Smoky Mountains in Sevierville, TN, just 25 mins from the slightly more bustling hubs of Knoxville and Pigeon

Second Quarter 2025 Highlights: — Total revenue increased 23% to $167.9 million — Net loss available to stockholders improved $16.1 million to $9.7 million — Adjusted EBITDA increased 139% to $24.8 million — Lindblad segment net yield per available guest night increased 13% to $1,241 — Occupancy increased to 86% from 78% Lindblad Expeditions Holdings,

— Record monthlyADV in cryptocurrency products CME Group, the world's leading derivatives marketplace, today reported its second-highest July average daily volume (ADV) of 21.9million contracts. The company set a July ADV record in 2024 with 24.8 million contracts. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume. July2025 ADV across asset classes includes: — Interest

(NASDAQ:ARTL), Lead investor Bartosz LipiÅ„ski, previously Head of Engineering at Solana Labs, will serve as a technical partner CUBE selected to secure storage, staking, and active DeFi execution of Artelo's digital asset treasury Artelo's Board approves authorization to expand Company's SOL treasury management strategy over time SOLANA BEACH, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) —

(NASDAQ:SAVA), Study in a TSC mouse model further demonstrates simufilam's anti-seizure activity Study conducted in collaboration with TSC Alliance using a well-accepted Tsc1-knockout model First clinical study for simufilam in TSC-related epilepsy expected to begin in H1 2026 AUSTIN, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a

(NASDAQ:ZVRA), CELEBRATION, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate and financial results for the second quarter 2025 on Tuesday, August 12, 2025, via a news release after

(NASDAQ:DYN), – Data from the DELIVER registrational expansion cohort is expected in late 2025, with a potential BLA submission for U.S. accelerated approval anticipated in early 2026 – WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven

(NasdaqGM:XOMA),(NasdaqGM:XOMAO),(NasdaqGM:XOMAP),(NASDAQ:LVTX), EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Aug. 04, 2025 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (NASDAQ: LVTX) announced today they have entered a definitive share purchase agreement (the “Purchase Agreement” and the transactions set forth in the Purchase Agreement, the “Transactions”) whereby XOMA